Unbiased transcriptome and protein profiling revealed that MALT1 inhibition potently suppressed NF-κB, PI3K/AKT/mTOR, and integrin signaling, and diminished MCL cell proliferation and dissemination. The gene discussed is NFKB1; the disease is mantle cell lymphoma.